Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Antibiotice logo — Cu știință și suflet alături de oameni!

Antibiotice

Cu știință și suflet alături de oameni!

Founded 1955 Romania Romania 575 employees Post Ipo Debt Total: $25.00M Pharmaceutical

General Information

Company Name Antibiotice
Founded Year 1955
Location Romania Romania +1
Employees 575
Industries Pharmaceutical
Funding Stage Post Ipo Debt
Social

Get notified when Antibiotice moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Antibiotice

Antibiotice is a prominent Romanian pharmaceutical company that has been an integral part of the industry since its establishment in 1955. The company's slogan, "Cu știință și suflet alături de oameni!," embodies its commitment to scientific advancement and compassion towards humanity. Specializing in the production of a wide range of pharmaceutical substances, including generic drugs for human and veterinary use, as well as the active ingredient Nystatin, Antibiotice has established itself as a key player in the field. With a diverse product portfolio comprising 160 generic drugs catering to various medical needs such as infectious diseases, cardiovascular, dermatological, digestive, and central nervous system-related pathologies, Antibiotice serves both the domestic and international markets. The company's reach extends to over 70 countries worldwide, earning it a prominent position in the global pharmaceutical landscape. Notably, Antibiotice holds the top spot globally in the production of Nystatin's active ingredient and is a leading manufacturer of antiinfective generic drugs in Romania, offering competitively priced medications with a focus on affordability and accessibility. Antibiotice's commitment to quality standards is evident through its adherence to internationally recognized certifications such as Good Manufacturing Practice (EU-GMP), Certificate of compliance with European Pharmacopoeia (COS), and Food and Drug Administration authorization (FDA). These certifications underscore the company's dedication to upholding superior quality across its operations, enabling its expansion into international markets and fostering trust among consumers and healthcare providers. Noteworthy is Antibiotice's recent €25.00M Post-IPO Debt investment on 10 November 2023, with the European Investment Bank (EIB) as the investor. This investment underscores the confidence of institutional investors in Antibiotice's growth potential and its continued contribution to the pharmaceutical industry. With its rich history, commitment to quality, and strategic investments, Antibiotice is poised to further enhance its global presence and make significant contributions to healthcare systems worldwide.

Taxonomy: pharmaceutical manufacturer, generic drugs, antibiotics, Nystatin, international market, quality standards, GMP, European Pharmacopoeia, FDA authorization, healthcare system, veterinary drugs, active ingredients

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Debt •••••• 1 •••• •••• 10 Nov 2023

Antibiotice Alternatives & Competitors

Antibiotice vs
Egis Pharmaceuticals PLC
Egis Pharmaceuticals PLC Hungary

Az Egis Gyógyszergyár Magyarország és Közép-Kelet-Európa egyik meghatározó generikus gyógyszergyára.

1895 employees
Antibiotice vs
Oddway International
Oddway International India

International Wholesale Specialty Pharmacy

21 employees
Pharmaceutical
Antibiotice vs
Unison Laboratories
Unison Laboratories

Producing affordable pharmaceutical solutions with a wide range of FDA-approved ETHICAL, GENERIC, an...

30 employees
Health Care, Manufacturing
Also compare with: Antibiotice vs QnQ Pharmacy QnQ Pharmacy Antibiotice vs LaGray Chemical Co ltd LaGray Chemical Co ltd Antibiotice vs AUROBINDO PHARMA LTD AUROBINDO PHARMA LTD

FAQ About Antibiotice

Cu știință și suflet alături de oameni!
Antibiotice was founded in 1955.
Antibiotice is headquartered in Romania.
Antibiotice operates in the following industries: Pharmaceutical.
Antibiotice has approximately 575 employees.
Antibiotice has completed 1 funding round, raising a total of $25.00M. The latest funding stage is Post Ipo Debt.
Top alternatives and competitors to Antibiotice include Egis Pharmaceuticals PLC, Oddway International, Unison Laboratories, QnQ Pharmacy, Sanjivani Paranteral Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Antibiotice and Egis Pharmaceuticals PLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Antibiotice and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy